Australia's LTR Pharma rises on commercial tie-up with US telehealth firm

Ltr Pharma

17/07/2026 03:06

** Shares of Australia's LTR Pharma LTP.AX rise as much as 17.2% to A$0.58, their biggest intraday pct gain since June 18
** Stock at its highest level since July 3
** LTP set to clock its second consecutive session of gains, if trend holds
** Stock up 1.9% in the week so far
** The clinical-stage biopharma firm signs a commercial agreement executed with Shed, a U.S. direct-to-consumer (DTC) telehealth platform
** Near 547,114 shares change hands, 1.0x the 30-day average volume 
** Stock has fallen 27.1% this year, including session moves

 (Reporting by Roshan Thomas in Bengaluru)
 ((Roshan.Thomas@thomsonreuters.com;))